Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances and challenges in the treatment of esophageal cancer
Shiming He, Jian Xu, Xiujun Liu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3379-3392
Open Access | Times Cited: 186

Showing 1-25 of 186 citing articles:

ALDH1: A potential therapeutic target for cancer stem cells in solid tumors
Yaolu Wei, Yan Li, Yen‐An Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 61
A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer
Qianhe Ren, Pengpeng Zhang, Xiao Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 38
Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression and chemoresistance by enhancing the secretion of chemotherapy-induced senescence-associated secretory phenotype via activation of DNA damage response pathway
Jianwei Zhang, Dan Zhang, Haisen Yin, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 29
Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma
Yixin Zhao, Heping Zhao, Mengyao Zhao, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 20, pp. 2638-2656
Open Access | Times Cited: 11
Effects of FAP+ fibroblasts on cell proliferation migration and immunoregulation of esophageal squamous carcinoma cells through the CXCL12/CXCR4 axis
Li‐Juan Duan, Shasha Cao, Fang Zhao, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access | Times Cited: 1
Exosomes derived from cancer-associated fibroblasts mediate response to cancer therapy
Nastaran Masoudi-Khoram, Mohammad Hasan Soheilifar, Shima Ghorbanifar, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 185, pp. 103967-103967
Closed Access | Times Cited: 20
P38 kinase in gastrointestinal cancers
Thuy Phan, Xu Hannah Zhang, Steven T. Rosen, et al.
Cancer Gene Therapy (2023) Vol. 30, Iss. 9, pp. 1181-1189
Open Access | Times Cited: 20
Long non‐coding RNAs with peptide‐encoding potential identified in esophageal squamous cell carcinoma: KDM4A‐AS1 ‐encoded peptide weakens cancer cell viability and migratory capacity
Bo Zhou, Yuyang Wu, Pei Cheng, et al.
Molecular Oncology (2023) Vol. 17, Iss. 7, pp. 1419-1436
Open Access | Times Cited: 19
High versus standard radiation dose of definitive concurrent chemoradiotherapy for esophageal cancer: A systematic review and meta-analysis of randomized clinical trials
Xiaofeng Wang, Hui Bai, Rui Li, et al.
Radiotherapy and Oncology (2023) Vol. 180, pp. 109463-109463
Closed Access | Times Cited: 17
Tumor associated macrophages in esophageal squamous carcinoma: Promising therapeutic implications
Jiale Zhang, Yanxin Dong, Shouyin Di, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115610-115610
Open Access | Times Cited: 17
Causal relationship between gut microbiota and risk of esophageal cancer: evidence from Mendelian randomization study
Kui Wang, Jiawei Wang, Yuhua Chen, et al.
Aging (2024) Vol. 16, Iss. 4, pp. 3596-3611
Open Access | Times Cited: 8
Precisely Self‐Cooperative Nanoassembly Enables Photothermal/Ferroptosis Synergistic Tumor Eradication
Xiaohong Yang, Chengcheng Feng, Pengfei Wang, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 18
Closed Access | Times Cited: 7
BCLAF1 drives esophageal squamous cell carcinoma progression through regulation of YTHDF2-dependent SIX1 mRNA degradation
Peipei Zhang, Weiguang Zhang, Xiaoqing Wang, et al.
Cancer Letters (2024) Vol. 591, pp. 216874-216874
Closed Access | Times Cited: 7
Current trends and future prospects of drug repositioning in gastrointestinal oncology
Nayeralsadat Fatemi, Mina Karimpour, Hoda Bahrami, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 6
The prognostic value of systemic immune-inflammation index in surgical esophageal cancer patients: An updated meta-analysis
Xiaoqu Li, Shuhao Zhang, Juan Lü, et al.
Frontiers in Surgery (2022) Vol. 9
Open Access | Times Cited: 24
Ferulic Acid Mitigates Growth and Invasion of Esophageal Squamous Cell Carcinoma through Inducing Ferroptotic Cell Death
Yu Cao, Hong Zhang, Jianming Tang, et al.
Disease Markers (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 24
USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1
Hongdian Zhang, Youming Han, Wanyi Xiao, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 16
Comprehensive analysis of ZNF family genes in prognosis, immunity, and treatment of esophageal cancer
Kunqiao Hong, Qian Yang, Haisen Yin, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Porphyromonas gingivalis promotes malignancy and chemo-resistance via GSK3β-mediated mitochondrial oxidative phosphorylation in human esophageal squamous cell carcinoma
Yiwen Liu, Fuyou Zhou, Haijun Yang, et al.
Translational Oncology (2023) Vol. 32, pp. 101656-101656
Open Access | Times Cited: 13
Esophageal cancer
Daniel C. Eisner
JAAPA (2024) Vol. 37, Iss. 4, pp. 19-24
Open Access | Times Cited: 5
Theranostic dye entrapped in an optimized blended-polymer matrix for effective photodynamic inactivation of diseased cells
Pragya Pallavi, Koyeli Girigoswami, Karthick Harini, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 398, Iss. 1, pp. 867-880
Closed Access | Times Cited: 5
Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: New opportunities towards molecularly targeted therapy
Xu Zhang, Yuxiang Wang, Linghua Meng
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 3, pp. 1054-1067
Open Access | Times Cited: 29
Brusatol induces ferroptosis in oesophageal squamous cell carcinoma by repressing GSH synthesis and increasing the labile iron pool via inhibition of the NRF2 pathway
Xu Zhu, Nannan Huang, Yao Ji, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115567-115567
Open Access | Times Cited: 12
THBS1 promotes angiogenesis and accelerates ESCC malignant progression by the HIF‐1/VEGF signaling pathway
Xiao Zhou, Qiaoxi Xia, Mantong Chen, et al.
Cell Biology International (2024) Vol. 48, Iss. 3, pp. 311-324
Closed Access | Times Cited: 4
MicroRNA‐196a‐5p facilitates the onset and progression via targeting ITM2B in esophageal squamous cell carcinoma
Dubiao Xian, Shubo Yang, Yunzhong Liu, et al.
Pathology International (2024) Vol. 74, Iss. 3, pp. 129-138
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top